Search by Drug Name or NDC
NDC 00169-2201-25 NovoLog Mix 70/30 100 [iU]/mL Details
NovoLog Mix 70/30 100 [iU]/mL
NovoLog Mix 70/30 is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN ASPART.
Product Information
NDC | 00169-2201 |
---|---|
Product ID | 0169-2201_ecfd53fb-5887-48df-bc66-c32f8ff0cf67 |
Associated GPIs | 2710407000D320 |
GCN Sequence Number | 050134 |
GCN Sequence Number Description | insulin aspart prot/insuln asp INSULN PEN 70-30/ML SUBCUT |
HIC3 | C4G |
HIC3 Description | INSULINS |
GCN | 17075 |
HICL Sequence Number | 023400 |
HICL Sequence Number Description | INSULIN ASPART PROTAMINE HUMAN/INSULIN ASPART |
Brand/Generic | Brand |
Proprietary Name | NovoLog Mix 70/30 |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | insulin aspart |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SUSPENSION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 100 |
Active Ingredient Units | [iU]/mL |
Substance Name | INSULIN ASPART |
Labeler Name | Novo Nordisk |
Pharmaceutical Class | Insulin Analog [EPC], Insulin [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA021172 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00169-2201-25 (00169220125)
NDC Package Code | 0169-2201-25 |
---|---|
Billing NDC | 00169220125 |
Package | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2201-25) / 3 mL in 1 SYRINGE, PLASTIC |
Marketing Start Date | 2021-07-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |